| human | Q5 |
| P2013 | Facebook username | jmluk |
| P1960 | Google Scholar author ID | eBCssO0AAAAJ |
| P6634 | LinkedIn personal profile ID | john-luk |
| P496 | ORCID iD | 0000-0002-6323-7940 |
| P3829 | Publons author ID | 1499817 |
| P1053 | ResearcherID | A-4085-2008 |
| P1153 | Scopus author ID | 7006777791 |
| P69 | educated at | Harvard Medical School | Q49121 |
| Karolinska Institutet | Q219564 | ||
| P108 | employer | Case Western Reserve University School of Medicine | Q5048331 |
| P735 | given name | John | Q4925477 |
| John | Q4925477 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q46799513 | 96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. |
| Q33499552 | A protein-based set of reference markers for liver tissues and hepatocellular carcinoma |
| Q35899490 | AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. |
| Q28567236 | Acrosome-specific gene AEP1: identification, characterization and roles in spermatogenesis |
| Q42873885 | Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration |
| Q53538850 | Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. |
| Q46698546 | An alternative DNA damage pathway to apoptosis in hematological cancers |
| Q34345765 | An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer |
| Q83450234 | An update on targeting Hippo-YAP signaling in liver cancer |
| Q78455942 | Applicability of intraoperative parathyroid hormone assay during thyroidectomy |
| Q36050864 | Applicability of tissue aspirate for quick parathyroid hormone assay to confirm parathyroid tissue identity during parathyroidectomy for primary hyperparathyroidism. |
| Q51910012 | Artificial neural networks and decision tree model analysis of liver cancer proteomes. |
| Q33302500 | Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. |
| Q37482114 | Biomarkers for early detection of liver cancer: focus on clinical evaluation. |
| Q50141333 | Biotinylated lipopolysaccharide binds to endotoxin receptor in endothelial and monocytic cells |
| Q52017854 | Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium. |
| Q81442669 | CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach |
| Q50251514 | Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo |
| Q44920086 | Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications |
| Q28580279 | Characterization of an acrosome protein VAD1.2/AEP2 which is differentially expressed in spermatogenesis |
| Q80376099 | Characterization of two novel LPS-binding sites in leukocyte integrin betaA domain |
| Q84064438 | Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients |
| Q35725150 | Circulating mortalin autoantibody--a new serological marker of liver cirrhosis |
| Q36420885 | Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. |
| Q46092058 | Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer |
| Q34070902 | Clinicopathologic and gene expression parameters predict liver cancer prognosis. |
| Q39466501 | Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. |
| Q53130040 | Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma. |
| Q33329606 | Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma |
| Q35073177 | Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy |
| Q35627178 | Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage |
| Q53380440 | Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. |
| Q44680777 | Different testicular gene expression patterns in the first spermatogenic cycle of postnatal and vitamin A-deficient rat testis |
| Q73304549 | Differential suppression by Tripterygium wilfordii extracts (traditional Chinese medicine) in the allogeneic rat mixed lymphocyte reaction |
| Q34383893 | Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma. |
| Q38210247 | Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. |
| Q50465044 | Efficient production of mouse and rat monoclonal antibodies against the O antigens of Salmonella serogroup C1, using LPS-coated bacteria as immunogen |
| Q40676637 | Embryotrophic factor-3 from human oviductal cells affects the messenger RNA expression of mouse blastocyst. |
| Q45086478 | Embryotrophic factor-3 from human oviductal cells enhances proliferation, suppresses apoptosis and stimulates the expression of the beta1 subunit of sodium-potassium ATPase in mouse embryos. |
| Q33547822 | Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker. |
| Q47234876 | Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction |
| Q81066450 | Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection |
| Q28740309 | Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma |
| Q44395085 | Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma |
| Q84239638 | Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma |
| Q45369081 | Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma |
| Q84453923 | HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma |
| Q46693145 | Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models |
| Q40150894 | Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. |
| Q42935421 | Hepatic tight junctions: from viral entry to cancer metastasis |
| Q81168633 | Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas |
| Q81627902 | High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma |
| Q24633776 | Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach |
| Q40615909 | Identification of liver-intestine cadherin in hepatocellular carcinoma--a potential disease marker. |
| Q48235590 | Identification of novel genes expressed during spermatogenesis in stage-synchronized rat testes by differential display |
| Q46875188 | Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property |
| Q40837072 | Immunosuppressive effects of Tripterygium wilfordii polysaccharide on LPS-stimulated human monocytes. |
| Q41066574 | In situ gene transfer into rat auxiliary liver transplant. |
| Q81506939 | Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases |
| Q79790573 | Increased solubility of integrin betaA domain using maltose-binding protein as a fusion tag |
| Q39619016 | Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. |
| Q30576918 | Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo |
| Q33961542 | Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. |
| Q34438689 | Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression |
| Q44544789 | Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients |
| Q79871757 | Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy |
| Q42653645 | Laparoscopic surgery induced interleukin-6 levels in serum and gut mucosa: implications of peritoneum integrity and gas factors. |
| Q45888400 | Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer |
| Q44317209 | Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506. |
| Q46504436 | Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection. |
| Q34103666 | MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. |
| Q79199324 | Minimally invasive endoscopic-assisted parathyroidectomy for primary hyperparathyroidism |
| Q33816796 | Molecular biology of gastric carcinoma: from laboratory to bedside. |
| Q36478827 | Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma. |
| Q35092706 | Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy |
| Q24672137 | Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement |
| Q43001140 | Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation |
| Q77358399 | Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator |
| Q28292533 | Oncofetal gene SALL4 in aggressive hepatocellular carcinoma |
| Q33298434 | Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. |
| Q43183165 | Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers |
| Q44956477 | Over-expression of inducible heat shock protein 70 in the gastric mucosa of partially sleep-deprived rats |
| Q34324655 | Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. |
| Q33514753 | Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. |
| Q28742950 | Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting |
| Q80033580 | Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b |
| Q38996944 | Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2. |
| Q38348179 | Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma. |
| Q39442425 | Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. |
| Q33401908 | Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma |
| Q39851613 | Proteomic identification of a monoclonal antibody recognizing caveolin-1 in hepatocellular carcinoma with metastatic potential. |
| Q33231146 | Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values |
| Q54392425 | Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance. |
| Q50189298 | Rapid and sensitive detection of Salmonella (O:6,7) by immunomagnetic monoclonal antibody-based assays |
| Q45728423 | Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation? |
| Q47387940 | Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma |
| Q56436732 | Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer |
| Q40570292 | Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. |
| Q44648829 | Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. |
| Q53303325 | Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma. |
| Q43595239 | Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma |
| Q73551294 | Signaling mechanisms of pertussis toxin-induced myelomonocytic cell adhesion: role of tyrosine phosphorylation |
| Q28504768 | Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells |
| Q50172252 | Specificity of monoclonal antibodies binding to the polysaccharide antigens (Vi, O9) of Salmonella typhi |
| Q40867724 | Suppression of cytokine production and cell adhesion molecule expression in human monocytic cell line THP-1 by Tripterygium wilfordii polysaccharide moiety. |
| Q42168735 | TNP-470 blockage of VEGF synthesis is dependent on MAPK/COX-2 signaling pathway in PDGF-BB-activated hepatic stellate cells. |
| Q27696166 | Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides |
| Q35893965 | Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma |
| Q74503364 | Telomerase activity in small cell esophageal carcinoma |
| Q73383331 | Telomerase activity in thyroid malignancy |
| Q47801246 | The "3Ps" world--from disease markers to biological therapeutics |
| Q30747633 | The embryotrophic activity of oviductal cell-derived complement C3b and iC3b, a novel function of complement protein in reproduction. |
| Q83816682 | The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis |
| Q44779004 | The healing effects of Centella extract and asiaticoside on acetic acid induced gastric ulcers in rats |
| Q43797203 | The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. |
| Q82761405 | The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma |
| Q37482146 | The use of small peptides in the diagnosis and treatment of hepatocellular carcinoma. |
| Q33287108 | Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma |
| Q36909491 | Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. |
| Q37915623 | Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. |
| Q34979073 | Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. |
| Q37138658 | Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma |
| Q37510658 | miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma |
| Q24595141 | microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma |
Search more.